http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009136669-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 |
| filingDate | 2008-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009136669-A |
| titleOfInvention | TREATMENT OF MELANOMA |
| abstract | 1. A method for treating melanoma, which method comprises administering in a therapeutically effective amount a compound of structure I, a tautomer of a compound, a pharmaceutically acceptable salt of a compound, a pharmaceutically acceptable salt of a tautomer or a mixture thereof, wherein the compound of structure I is! ! wherein ! A denotes a group selected from! or , ! R1 is selected from H and straight or branched chain alkyl groups having from 1 to 6 carbon atoms. ! 2. The method according to claim 1, in which R1 represents a methyl group and the compound of structure I is a compound of structure IA! . ! 3. The method according to claim 1, in which R1 is hydrogen and the compound of structure I is a compound of structure IB! . ! 4. The method according to claim 1, in which R1 denotes a methyl group and the compound of structure I is a compound of structure IC! . ! 5. The method according to claim 1, in which the individual is injected lactate compounds of structure I or its tautomer. ! 6. The method according to claim 1, in which the individual is a human. ! 7. The method according to claim 1, in which the melanoma is a metastatic melanoma. ! 8. The method according to claim 1, in which the melanoma is a superficially spreading melanoma, nodular malignant melanoma, acral-lentiginous melanoma, lentiginous malignant melanoma or lentiginous melanoma of the mucous membranes. ! 9. The method of claim 1, wherein the melanoma is a cutaneous or extradermal form of melanoma. ! 10. The method of claim 1, wherein the melanoma is ocular melanoma or clear cell soft tissue sarcoma. ! 11. The method according to claim 1, in which one or more |
| priorityDate | 2007-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.